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Abstract
The inner mitochondrial membrane harbors a large number of proteins that display a wide range of topological arrangements. The
majority of these proteins are encoded in the cell’s nucleus, but a few polytopic proteins, all subunits of respiratory chain complexes are
encoded by the mitochondrial genome. A number of distinct sorting mechanisms exist to direct these proteins into the mitochondrial inner
membrane. One of these pathways involves the export of proteins from the matrix into the inner membrane and is used by both proteins
synthesized within the mitochondria, as well as by a subset of nuclear encoded proteins. Prior to embarking on the export pathway, nuclear
encoded proteins using this sorting route are initially imported into the mitochondrial matrix from the cytosol, their site of synthesis. Protein
export from the matrix into the inner membrane bears similarities to Sec-independent protein export in bacteria and requires the function of
the Oxa1 protein. Oxa1 is a component of a general protein insertion site in yeast mitochondrial inner membrane used by both nuclear and
mitochondrial DNA encoded proteins. Oxa1 is a member of the conserved Oxa1/YidC/Alb3 protein family found throughout prokaryotes
throughout eukaryotes (where it is found in mitochondria and chloroplasts). The evidence to demonstrate that the Oxa1/YidC/Alb3 protein
family represents a novel evolutionarily conserved membrane insertion machinery is reviewed here.
D 2002 Elsevier Science B.V. All rights reserved.
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1. Introduction
The mitochondrion, an eukaryotic organelle, harbors
many protein complexes which function in metabolic path-
ways essential for the cell. The most notable of these is the
aerobic production of energy in the form of ATP by a
process termed oxidative phosphorylation. Mitochondria
contains two membranes, an outer and an inner membrane,
and two aqueous compartments, the mitochondrial matrix,
which is enclosed by the inner membrane and a space
located between the outer and inner membranes, termed
the intermembrane space. Each of these compartments
contains their own specific subset of mitochondrial proteins.
The inner membrane is a protein-rich membrane, harboring
many multi-subunit protein complexes involved in pro-
cesses such as substrate and nucleotide transport, oxidative
phosphorylation and proteolysis. The proteins residing in
the inner membrane are coded for by genes located in either
the nucleus or in the mitochondrial genome. Consequently,
these proteins are either synthesized in the cell’s cytoplasm
or in the mitochondrial translational apparatus located in the
matrix space. Prior to assembly, these proteins must be
sorted from their sites of synthesis to become inserted into
the inner mitochondrial membrane.
Research over the past years has indicated that a number
of distinct pathways exist to sort the nuclear and mitochond-
rially encoded proteins to the inner membrane. The main
focus of the review shall be devoted to the recent character-
ization of one of these pathways. This pathway, termed the
Oxa1 pathway, involves export of proteins from the mito-
chondrial matrix into the inner membrane and is used by the
mitochondrially encoded membrane proteins as well as a
subset of nuclear encoded proteins.
2. Import of nuclear encoded proteins into mitochondria
The nuclear encoded proteins located in the inner mem-
brane mitochondria are synthesized as precursor proteins in
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the cell’s cytoplasm. These proteins are targeted to and
become imported into the mitochondria, a process thought
to occur in a post-translational manner [1–6]. Nuclear
encoded mitochondrial proteins contain targeting sequences,
which ensure their initial targeting to the mitochondria. For
many of these proteins, these mitochondrial targeting
sequences are located at the amino-(N)-terminus of the
polypeptide, and they become proteolytically removed by
the mitochondrial processing peptidase (MPP) during or
following import into the mitochondria [1–6]. In some
instances, however, proteins destined for the inner mem-
brane contain internal, non-cleavable mitochondrial target-
ing sequences [4–6].
Import of nuclear encoded proteins to the mitochondrial
inner membrane requires initial translocation across the
outer mitochondrial membrane, a step mediated by a general
import machinery located in the outer membrane, the trans-
locase of the outer membrane (TOM) complex [1–3] (Fig.
1). Passage across, or insertion into, the inner membrane
requires an energized inner membrane and is facilitated by
another proteinaceous machinery, the translocase of the
inner membrane (TIM) complex. Two TIM translocases
differing in substrate specificity, the Tim17–23 complex
[4–6] and the Tim22–54 machinery have been identified
[7,8]. The Tim17–23 complex appears to represent the
general import machinery and is used by the presequence-
targeted precursor proteins [4–6] (Fig. 1). Translocation of
segments of preproteins across the inner membrane via this
complex requires the co-operation of another component,
Tim44 and the ATP-driven molecular chaperone mt-Hsp70
and its co-chaperone Mge1 [4–6]. The Tim22–54 complex
mediates the membrane insertion of a subset of polytopic
inner membrane proteins, such as members of the metabo-
lite carrier family and is reviewed by R.E. Jensen and C.D.
Dunn in this issue [7,8].
Following the import into the mitochondria, precursor
proteins can undergo a number of further maturation events,
including proteolytic removal of mitochondrial targeting
sequences, sorting to the inner membrane, folding and
assembly into their functional oligomeric structures.
3. Proteins encoded by the mitochondrial genome
Although the majority of the proteins which make up
these complexes embedded in the inner membrane are
encoded by genes in the cell nucleus, a small percentage
of the proteins (seven in the yeast Saccharomyces cerevi-
siae), are encoded by the mitochondrial genome located in
the matrix compartment. These seven proteins are integral
inner membrane proteins, all subunits of the respiratory
chain complexes. These proteins are, cytochrome b, of the
cytochrome bc1 complex, subunits 1, 2 and 3 of the
cytochrome oxidase complex (Cox1, Cox2 and Cox3 pro-
teins, respectively) and F1Fo-ATP synthase subunits,
ATPase 6, ATPase 8 and ATPase 9. As outlined in more
detail below, current evidence indicates that these mitochon-
drial gene products are inserted into the inner membrane as
they are undergoing translation on the mitochondrial ribo-
somes. Each of these proteins represents essential subunits
of their respective respiratory chain complexes. Failure of
these proteins to reach the inner membrane results in a
respiratory deficient phenotype for the yeast. Assembly of
these multi-subunit respiratory chain complexes thus
involves the coming together of proteins encoded by the
nuclear and mitochondrial genomes in a coordinated fashion
and with a precise stoichiometry.
4. Topogenic signals
Integral inner membrane proteins display a wide varia-
tion in their membrane topologies, differing with respect to
the number of times they span the inner membrane and also
in the location of their N- and C-termini (intermembrane
space-exposed, ‘‘out’’ or matrix-exposed, ‘‘in’’). Some pro-
teins are anchored to the membrane by one membrane
spanning or transmembrane segments (monotopic), while
others span the inner membrane multiple times (polytopic
proteins). All inner membrane proteins contain sequence
determinants, so-called topogenic signals, which ensure the
sorting of the protein to the inner membrane and which
determine the attainment of their orientation in the mem-
brane. These signals generally comprise hydrophobic cores
(approximately 17–22 amino acids) flanked on both sides
by charged amino acid residues [9]. For nuclear encoded
inner membrane proteins, the topogenic signal, although
distinct from the mitochondrial targeting signals, may oper-
ate in conjunction with the mitochondrial targeting informa-
tion, to ensure sorting of the protein directly into the inner
membrane while traversing the TIM machinery. In most
cases, the topogenic signals comprise an integral part of the
sorted protein, i.e. the transmembrane segment. In a few
Fig. 1. Model of the protein translocases of the outer and inner membranes
involved in the import and sorting of proteins in mitochondria. See text for
details. Abbreviations: OM, outer membrane; TOM, translocase of the outer
membrane; IM, inner membrane; TIM, translocase of the inner membrane.
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cases, however, they are proteolytically removed by a
peptidase (the Imp1/Imp2 complex) in the intermembrane
space [10,11], following sorting of the protein to the correct
orientation in the membrane.
5. Pathways of protein sorting to the inner membrane
Bearing in mind the wide variety of final orientations of
inner membrane proteins, together with their two possible
sites of synthesis (cytoplasm for the nuclear encoded, and
mitochondrial matrix for the mitochondrially encoded pro-
teins), one mechanism alone cannot account for the mode of
operation of all topogenic signals. Research from a number
of laboratories over the past years has confirmed that a
number of different sorting pathways may exist [4–9].
5.1. Sorting by translocation arrest
The topogenic signals of some nuclear encoded inner
membrane proteins function to arrest their translocation
during import, at the level of the inner membrane, the
essence of the ‘‘stop transfer’’ model [12–18]. Proteins
using this pathway, following initiation of translocation
across one of the two protein translocation machineries of
the inner membrane (either the Tim17–23 or Tim22–54
complex) to become directly sorted to the inner membrane,
laterally from the TIM complex (Fig. 2). Presequence-
targeted proteins sorted to the inner membrane by a ‘‘stop-
transfer’’ mechanism initiate import via the Tim17–23
machinery, where they are thought to become arrested and
undergo a lateral transfer directly into the inner membrane
(Fig. 2) [4,9,17,18].
Some proteins bearing internal mitochondrial targeting
signals also use a translocation arrest and direct membrane
insertion mechanism to reach the inner membrane. This
group of proteins includes members of the carrier family,
such as the ADP/ATP translocator, which employs the
Tim22–54 translocase for membrane insertion [5–8]. The
Tim22–54 translocase functions closely with a number of
small soluble proteins, Tim8, 9, 10, 12 and 13, resident
proteins of the intermembrane space to mediate the import
and insertion of its substrate proteins (Fig. 1) (see accom-
panying review by Jensen et al.) [5–7]. This pathway
clearly differs from that used by N-terminal targeted pro-
teins, which are sorted by translocation arrest in the Tim17–
23 machinery.
5.2. Sorting by export from the mitochondrial matrix
Nuclearly encoded polytopic inner membrane proteins
can be divided into two classes, those that do not have
prokaryotic counterparts and those that do. Proteins
belonging to the first class include proteins such as the
members of the carrier family, e.g. the ADP/ATP carrier
family and components of the TIM machineries. As
mentioned earlier, all available evidence suggests that these
proteins become directly inserted into the inner membrane
following a translocation arrest mechanism during import,
in a manner facilitated by the TIM machinery [4–7]. On
the other hand, members of the second class of nuclearly
encoded proteins, i.e. those which have prokaryotic equiv-
alents and which are targeted to the mitochondria by N-
terminal mitochondrial targeting signals are sorted by a
very different mechanism. Proteins following this second
route do not become arrested during import over the inner
membrane, but rather continue into the matrix, from where
they insert into the inner membrane via an independent
export step [9,19–21].
Proteins sorted to the inner membrane via an export
pathway from the matrix display a diverse range of top-
ologies and include both nuclear as well as mitochondrially
encoded proteins. Sorting of proteins by export from the
matrix was initially described for subset of inner membrane
proteins, which are oriented in the membrane in such a
manner that their N-termini are exposed to the intermem-
brane space (Fig. 3) [19–22]. Examples of these proteins
include subunit 9 (Su9) of the F1Fo-ATP synthase, subunit 2
of the mitochondrially encoded cytochrome oxidase com-
plex (Cox2) and a polytopic nuclear encoded protein, Oxa1
(Fig. 3).
For nuclear encoded proteins sorted to the inner mem-
brane along this export pathway, the steps of protein import
and export are two distinct processes, which can be exper-
imentally dissected. These proteins are first completely
imported over the Tim17–23 machinery into the mitochon-
drial matrix where their N-terminal targeting presequences
are proteolytically removed. Following maturation, these
proteins embark a second independent membrane insertion/
Fig. 2. Sorting of presequence-targeted proteins by translocation arrest
during import. See text for details. Abbreviations, MPP, mitochondrial
processing peptidase; IM, inner membrane.
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export step to become inserted into the inner membrane
[9,19–21,23]. All the nuclear encoded proteins sorted in this
manner, which have been characterized to date, achieve a
final membrane orientation where their N-terminal regions
are located in the intermembrane space. Hence, the mem-
brane insertion of these proteins from the matrix is coupled
to the export of N-terminal hydrophilic regions across the
membrane to the intermembrane space. Accordingly, this
translocation event has been referred to as ‘‘N-terminal tail
export’’ [19–21,23]. The process of N-terminal tail export
bears resemblance to the previously characterized process of
N-terminal tail export in prokaryotes (see below) [9,19,23–
25].
Export of the N-terminal tail of the nuclear encoded
proteins from the matrix to the intermembrane space
requires an energized inner membrane. Dissipation of the
membrane potential (following post-translational import
into the mitochondrial matrix) resulted in the accumulation
of the imported proteins in the mitochondrial matrix [19–
21,23]. As will be outlined in detail below, insertion of
these N-terminal tail exported proteins into the inner
membrane is not a spontaneous event, but rather is
facilitated by a protein complex in the inner membrane,
termed Oxa1.
The process of protein export from the matrix was
first demonstrated for presequence-targeted inner mem-
brane proteins, which were initially imported into the
mitochondrial matrix in a post-translational fashion [19–
21]. It was then subsequently shown that mitochondrial
gene products synthesized within the matrix also undergo
a similar insertion-export step to attain their orientation in
the inner membrane [20,22]. Membrane insertion of the
transmembrane segments of these proteins, like that of
the nuclear encoded ones, is also coupled to the export of
hydrophilic segments of the proteins completely across
the membrane to the intermembrane space. Of all the
mitochondrial gene products, the insertion of subunit 2 of
the cytochrome oxidase complex (Cox2) probably repre-
sents the best-characterized pathway [20,22,26,27] (Fig.
4).
Cox2 is an integral membrane protein, which spans
the inner membrane twice in an Nout–Cout orientation.
Attainment of this topology hence requires the insertion
of two transmembrane segments and is coupled to the
export of hydrophilic, negatively charged N- and C-
termini. Cox2 is synthesized in the mitochondrial matrix
as a precursor protein with an N-terminal cleavable
presequence (pCox2) (Fig. 4). Insertion of pCox2 to a
final Nout–Cout orientation was observed to be dependent
on the presence of an energized inner membrane [20,22].
In particular, export of the carboxy-(C)-terminal region,
which is relatively long (approximately 150 amino acid
residues) and bears a strong net negative charge, dis-
played a stringent requirement for a membrane potential
across the inner membrane [20,22]. Following export,
pCox2 associates with a membrane-bound chaperone,
Cox20 [28]. Association with Cox20 is necessary for
proteolytic removal of the N-terminal presequence of
pCox2, which results in the generation of the mature
size Cox2 species [28]. This processing event is catalyzed
by the Imp1/Imp2 protease located at the outer surface of
the inner membrane [10,11]. Current evidence suggests
that Cox2, like the other mitochondrial gene products
destined for the inner membrane, become inserted into
the membrane as they are undergoing synthesis on
mitochondrial ribosomes, i.e. in a co-translational fashion
[26,29,30]. The insertion of Cox2 and export of its N-
and C-termini is not a spontaneous event, but rather is
facilitated by the Oxa1 protein complex located in the
inner membrane [22,27].
Fig. 3. Model of inner membrane proteins, ATPase 9, Cox2 and Oxa1, used
in the initial analysis of mitochondrial protein export. The genomes on
which these proteins are encoded are indicated in boxes below each protein.
Each protein has a Nout-orientation in the inner membrane and in each case,
the hydrophilic regions exposed to the matrix bear a net positive charge (+).
The intermembrane space exposed segments bear either a net negative
charge ( ) or are neutral. Abbreviations, IM, inner membrane; Imp1, inner
membrane peptidase 1; mt-DNA, mitochondrial DNA; S. cerevisiae,
Saccharomyces cerevisiae; N. crassa, Neurospora crassa.
Fig. 4. Model of the export pathway of the mitochondrially encoded protein
cytochrome oxidase subunit 2 (Cox2) following synthesis as a precursor
form (pCox2) in the matrix. See text for details. Note for simplicity, the
pCox2 species, prior to export, is depicted as a fully synthesized
polypeptide in the mitochondrial matrix. As outlined in the text, current
evidence suggest that pCox2 is inserted into the inner membrane at the
Oxa1 site in a co-translational manner. Abbreviations see Fig. 1.
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6. The Oxa1 protein
The Oxa1 protein was initially identified in two inde-
pendent genetic screens designed to identify yeast proteins
involved in the biogenesis of the mitochondrial respiratory
chain complexes [31,32]. Characterization of a respiratory
deficient mutant lacking cytochrome oxidase activity lead to
the cloning of a nuclear gene termed OXA1, for oxidase
assembly [31–33]. Oxa1 is a 36 kDa protein located in the
mitochondrial inner membrane, where it spans the inner
membrane five times in a Nout–Cin orientation (Fig. 3)
[21,31–33]. Sequence analysis of the Oxa1 protein indi-
cated that it represented a highly conserved protein, present
throughout both the eukaryotic and prokaryotic kingdoms
(see below) [31–37].
Further characterization of oxa1 mutants indicated that
the observed respiratory deficiency was not caused by a lack
of cytochrome oxidase assembly alone, but rather was also
due to compromised F1Fo-ATP synthase and cytochrome
bc1 complex activities [31–33,38–40]. The pleiotrophic
phenotype displayed by oxa1 mutants was indicative of a
general function of Oxa1 in the biogenesis of inner mem-
brane proteins.
The first hint that Oxa1 may be involved in mediating
the insertion of proteins from the matrix into the inner
membrane came from an observation made with a temper-
ature-sensitive yeast mutant of Oxa1, pet ts1402, which had
been isolated by Bauer et al. [32]. When exposed to the
non-permissive temperature of 37 jC, an accumulation of
the precursor form of cytochrome oxidase subunit 2
(pCox2) was detected in this mutant [32]. As outlined
previously, the precursor of Cox2 undergoes maturation
by the Imp1/Imp2 peptidase in the intermembrane space,
following its membrane potential-dependent export to an
Nout–Cout topology (Fig. 4) [20,22]. Thus, accumulation of
the pCox2 species in this mutant at the non-permissive
temperature reflected either lack of correct membrane
insertion/export or the lack of Imp1/Imp2 activity. Using
mitochondria isolated from the oxa1 mutant, it could be
shown that Oxa1 plays an essential role in the sorting of
newly synthesized pCox2 from the matrix to the intermem-
brane space, rather than in the subsequent event of proteo-
lytic maturation [27]. The phenotype of the pet ts1402
mutant was selectively induced in vitro, by briefly exposing
mitochondria, which had been isolated from this strain
grown at permissive temperature, to the elevated non-
permissive temperature of 37 jC [27]. Following induction
of the phenotype in the isolated mitochondria in this
manner, newly synthesized pCox2 accumulated in the
matrix as it failed to undergo export to an Nout–Cout
topology [27]. In an independent study performed by He
and Fox [22], the export of Cox2 and Cox2-derivatives was
found to be inhibited in oxa1 null mutant in vivo.
In addition to playing an essential role in the biogenesis
of Cox2, Oxa1 was subsequently shown to be required for
the insertion of those nuclear encoded proteins, including
Oxa1 itself, which undergo N-tail export and insertion into
the inner membrane, following prior import into mitochon-
drial matrix [22,26–29].
In summary, the Oxa1 complex acts as a general insertion
site mediating the insertion of both nuclear and mitochond-
rially encoded proteins from the mitochondrial matrix into
the mitochondrial inner membrane.
7. Oxa1 function is not limited to the insertion of N-tail
exported proteins
The function of Oxa1 was initially demonstrated to be
directly required for the export of at least the N-terminal tail
region of these membrane proteins [26,27]. Export of other
regions of membrane proteins to the intermembrane space,
such as hydrophilic loops between neighboring transmem-
brane domains as well as C-terminal hydrophilic segments
were also inhibited in oxa1 mutant mitochondria [22,26–
28]. Export of the N-terminal tails of these proteins from the
matrix was found to kinetically precede and even be a
prerequisite for, the export of internal and C-terminal hydro-
philic regions of the proteins, however [20,21,26]. Thus,
from these initial studies, it could not be determined whether
the export of domains, other than the N-terminal regions,
directly required the function of the Oxa1 complex or not
[26].
The function of Oxa1 was recently shown not to be
limited to the insertion of N-tail exported membrane
proteins, but rather it extends to the insertion of polytopic
proteins bearing N-termini that are retained in the mito-
chondrial matrix. Mitochondrial gene products, subunit 1
(Cox1) and subunit 3 (Cox3) of the cytochrome oxidase
complex and cytochrome b of the cytochrome bc1 com-
plex, span the inner membrane several times (12, 7 and 8
times, respectively), in a manner where their N-termini
reside in the mitochondrial matrix [41,42]. Attainment of
this topology thus involves the translocation of hydrophilic
loops between neighboring transmembrane segments,
across the inner membrane, to their final destination in
the intermembrane space. Unlike the export of Cox2, the
insertion of these other proteins did not display a strict
requirement for the presence of an energized inner mem-
brane [29,43]. As was initially demonstrated for Cox2, the
Oxa1 complex also supports the insertion of other mito-
chondrially encoded proteins into the inner membrane
[28]. Using mitochondria isolated from the temperature-
sensitive oxa1 mutant, newly synthesized Cox1, Cox3 and
cytochrome b were shown to display a dependency on
Oxa1 function for their efficient integration into the inner
membrane. Thus, it was concluded that the function of
Oxa1 was not to be limited to the export of N-terminal
tails of membrane proteins, but rather it represents a
component of a general membrane insertion site for a
class of proteins of the mitochondrial inner membrane
[29].
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8. Oxa1 directly facilitates membrane insertion of newly
synthesized proteins
From the studies described above, it became evident that
the function of Oxa1 was required for the insertion of a
variety of proteins, both nuclear and mitochondrially
encoded, into the inner membrane. Using a chemical
cross-linking approach, it could be demonstrated that
Oxa1 directly interacts with substrate proteins as they are
undergoing the insertion step into the inner membrane
[26,29]. Nascent polypeptide chains being synthesized in
mitochondria, as well as newly imported nuclear encoded
proteins, were shown to physically interact directly with
Oxa1, as they were undergoing export from the matrix [26].
Of the mitochondrial gene products, newly synthesized
Cox1, Cox2, Cox3 and cytochrome b were found to physi-
cally interact with Oxa1 [26,29]. Although the Oxa1-medi-
ated insertion of Cox2 into the membrane displays a strong
dependency on the presence of membrane potential, the
interaction of newly synthesized Cox2 with Oxa1 occurred
even in the absence of an energized membrane [29]. Thus
the interaction of Oxa1 with Cox2 and possibly other
membrane proteins occurs early and independently of mem-
brane insertion. In summary, based on their dependency on
the presence of Oxa1 for insertion and the observed physical
interaction of Oxa1 with its substrates, it was concluded that
Oxa1 was directly required for the membrane insertion of
these proteins into the inner membrane [26,29].
The mitochondrially encoded proteins were shown to
interact with Oxa1 early during their biogenesis, i.e. during
their synthesis as nascent polypeptide chains [26,29]. Cross-
linking of full-length polypeptide chains to Oxa1 was
obtained only when the cross-linking was performed during
ongoing protein synthesis. If completion of protein synthesis
was blocked by the addition of chloramphenicol prior to
cross-linking, nascent chains, rather than full-length proteins,
were found in association with Oxa1 [29]. Thus a nascent
polypeptide chain could be cross-linked to Oxa1 prior to, but
independent of, the completion of its synthesis. Moreover, the
association of Oxa1 with the nascent chain undergoing
membrane insertion was enhanced by the presence of the
associated ribosome. Release of the ribosome by the addition
of puromycin (puromycin causes premature release of the
nascent chain from the ribosome) prior to cross-linking,
resulted in a strong decrease of the level of nascent polypep-
tide which remained in physical proximity to Oxa1 [29].
In summary, Oxa1 interacts directly with the nascent
chain as it is undergoing membrane insertion. This inter-
action is supported by the presence of the associated
ribosome (Fig. 5). Mitochondrial ribosomes actively under-
going translation have been observed to be in close prox-
imity to the mitochondrial inner membrane in vivo [44,45].
A close coupling of the synthesis of the membrane proteins
encoded by the mitochondrial DNA and their translocation
into the membrane has been suggested to occur [30,46,47].
Consequently, mitochondrial gene products destined for the
inner membrane are synthesized directly at their site of
membrane insertion, the Oxa1 complex.
A close coupling of the translation machinery with the
Oxa1 insertion site in this manner may serve two purposes.
First, coupling of translation and translocation events would
circumvent the possibility of these hydrophobic proteins
being synthesized in the matrix prior to their membrane
insertion, where they may aggregate. Second, a co-transla-
tional insertion event may be energetically favorable by
providing a driving force required for the insertion and
translocation events.
How are mitochondrial ribosomes undergoing translation
targeted to the Oxa1 complex? How is this interaction of the
translating ribosome with the Oxa1 complex maintained?
The molecular basis for such an interaction may be complex
in nature and would also need to ensure that the translating
ribosome could be distinguished from one not undergoing
translation. Binding of the translating ribosome to the Oxa1
complex may involve a direct interaction of Oxa1 with
component(s) of the translating ribosomes, such as a riboso-
mal subunit, the mRNA being translated and/or the nascent
chain emerging from the ribosome. Interestingly, Fox et al.
[30,46,47] have genetically identified a number of transla-
tional activator proteins, which are integral inner membrane
proteins. By interacting with the 5V untranslated leaders of
specific mRNAs, Fox [30,46–48] has proposed that these
membrane embedded translational activators may serve to
ensure that initiation of synthesis of the membrane proteins
occurs directly at the level of the inner membrane. It is
therefore plausible that such translational activator proteins
may closely cooperate with the Oxa1 complex to facilitate the
recognition and binding of ribosomes and their associated
mRNAs. By doing so, both the initiation and the completion
of synthesis of these membrane proteins would occur in the
environment of the Oxa1-membrane insertion site.
It is possible that ribosomes undergoing translation at the
inner membrane surface are directly in contact with Oxa1 or
components of the Oxa1 complex. The matrix-exposed
hydrophilic regions of Oxa1, in particular the C-terminal
segment (approximately 100 residues in length and basic in
Fig. 5. Insertion of mitochondrially encoded polytopic proteins into the
inner membrane, mitochondrial ribosome activity undergoing protein
translation, are closely associated with the mitochondrial inner membrane.
Nascent peptides physically associate with Oxa1 as they are undergoing
insertion. Current evidence suggests that a component(s) of the translating
ribosome may bind directly to the Oxa1 complex. See text for more details.
Abbreviations, Mt-ribosome, mitochondrial ribosome; IM, inner mem-
brane.
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nature) may be involved in recognizing and/or binding
component(s) of the translating ribosome. Further character-
ization of the Oxa1 complex is required to elucidate the
molecular details of how co-translational insertion of pro-
teins into the membrane is ensured.
9. Does the Oxa1 complex represent the only membrane
insertion site for proteins being exported from the
matrix?
Oxa1 represents a component of the general protein
insertion machinery involved in the insertion of a variety
of inner membrane proteins differing both in their mem-
brane orientation and in their site of synthesis. A number of
independent experimental observations would support that
the Oxa1 complex, however, may not be the only site for
insertion of proteins into the inner membrane from the
matrix. Increasing evidence would indicate that the level
of dependency on Oxa1 for membrane insertion varies
among different substrate proteins [26,29]. Of all the sub-
strates tested, the mitochondrially encoded Cox2 protein
displayed the strictest dependency on Oxa1 for membrane
insertion [22,27]. In contrast, when investigated in parallel,
the insertion of other newly synthesized mitochondrially
encoded proteins studied, in particular cytochrome b, Cox3
and ATPase 6, was only partially impaired in the oxa1
temperature-sensitive mutant mitochondria [29]. In addition,
although the Oxa1 complex was shown to be required for
the membrane insertion from the matrix of newly imported
Oxa1 precursor protein, in contrast to pCox2, the inhibition
of Oxa1 insertion in the oxa1 mutant was not complete [26].
This observation is indicative of the presence of an alter-
native insertion activity in the inner membrane. This notion
is reinforced when one considers that the oxa1 null mutant
can be rescued by expression of the Oxa1 from a plasmid-
borne gene [31,34,35]. If the presence of Oxa1 in the
mitochondrial membrane was obligatory for membrane
insertion, the oxa1 null mutant should not have been able
to be complemented in this manner. Although it cannot be
excluded that some proteins may undergo a limited sponta-
neous insertion into the inner membrane, taken together,
these observations may be indicative of an alternative Oxa1-
independent insertion process which displays partial over-
lapping specificity with the Oxa1 machinery.
Further evidence for the existence of an alternative Oxa1-
independent insertion process stems from the elegant work
of Dujardin et al. [49,50]. Taking a genetic approach to
understanding the function of Oxa1, Dujardin reported that
mutations in the transmembrane region of cytochrome c1
restored growth of the oxa1 null mutant on non-fermentable
carbon sources [49]. Although the molecular basis for this
intriguing observation is not yet understood, the finding
further illustrates that the inner membrane displays signifi-
cant flexibility to facilitate insertion of its resident proteins.
In a different study, Dujardin et al. [50] showed that deletion
of the gene encoding Yme1, an inner membrane protease in
the oxa1 null mutant background, resulted in the restoration
of the F1Fo-ATP synthase to wild-type levels. Thus, under
conditions where the Yme1-catalyzed proteolysis of non-
assembled subunits of the Fo-ATP synthase was prevented,
the efficiency of the Oxa1-independent insertion step of Fo-
ATP synthase subunits was apparently sufficient to ensure
assembly of a functional ATP synthase [50].
What is the molecular basis for the Oxa1-independent
insertion pathway(s)? Evidence that another protein, Mba1
may represent and Oxa1-independent insertion site was
recently presented [51]. Mba1 was originally identified as
a multicopy suppressor of a yeast mutant lacking either the
Yta10 (Afg3) or Yta12 (RCA1) proteases in the mitochon-
drial inner membrane [52,53]. Interestingly, this screen also
identified Oxa1 as a suppressor of the yta10(afg3) and
yta12(rca1) null mutant strains [52,53]. Like Oxa1, the
presence of Mba1 was shown to influence the efficiency
of insertion of a number of mitochondrially encoded inner
membrane proteins [51]. Furthermore, Mba1, like Oxa1,
interacts directly with newly synthesized proteins, which
become inserted into the inner membrane. Although the
function and substrate specificity of Oxa1 and Mba1 appear
to overlap, available genetic and biochemical data would
suggest that Mba1 is a component of an alternative, Oxa1-
independent insertion site for membrane proteins [51].
Other candidate components for such an alternative
Oxa1-independent insertion mechanism may also involve
the inner membrane proteins Pnt1 or Cox18. Pnt1 was
identified in a genetic screen designed to identify proteins
involved in the export of Cox2 and derivatives [54]. Cox18,
a protein required for the assembly of the cytochrome
oxidase, shares some sequence similarity with Oxa1 [55].
Further characterization of both of these proteins is required
to fully elucidate their possible involvement in the mem-
brane insertion process (see Note Added in Proof).
10. Oxa1 is a member of a novel family of evolutionarily
conserved proteins involved in the membrane insertion
of proteins
According to the endosymbiont hypothesis, the inner
membrane of mitochondria and the thylakoid membrane
of chloroplasts are derived from the plasma membrane of
their respective prokaryotic ancestors. Many of the mito-
chondrial inner membrane proteins are homologous to
bacterial proteins thus reflecting their prokaryotic ancestry.
Analysis of the charge-distribution profile of their hydro-
philic segments on either side of the inner membrane
suggested that these mitochondrial proteins adhere to the
‘‘positive-inside’’ rule of protein sorting, initially described
for bacterial membrane proteins [56–59]. This observation
led to the prediction some years ago that these mitochon-
drial proteins are sorted to their inner membrane orientations
along a prokaryotic type of export pathway [9,56].
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Further characterization of the Oxa1-mediated export
pathway used by mitochondrial inner membrane proteins
demonstrated it to resemble the bacterial Sec-independent
membrane insertion pathway with respect to energetic
requirements, adherence to the ‘‘positive-inside’’ rule and
independence on the Sec translocation machinery [19,20,23].
In mitochondria, the involvement of a SecYEG-type of
machinery was considered unlikely, as there is no indication,
at least in yeast mitochondria, for the existence of a Sec
machinery [60].
The most convincing evidence to demonstrate that the
Oxa1-mediated export pathway in mitochondria was indeed
conserved from the prokaryotic ancestors of mitochondria
was revealed following the functional characterization of
Oxa1 homologs from other organisms.
Oxa1 is an evolutionarily conserved protein found
throughout prokaryotes and eukaryotes. In prokaryotes it
is found in gram positive and gram negative bacteria, where
it is known as YidC (in Escherichia coli) or the conserved
60 kDa inner membrane protein, IM60 [37,61,62]. In
eukaryotes, both mitochondrial and chloroplast homologs
have been reported [31,32,36]. The Oxa1 homolog in
chloroplasts is termed Albino3 (Alb3) and it is an integral
membrane protein of the thylakoid membrane system [36].
Following the elucidation of the role of Oxa1 in the
mitochondrial protein export pathway, it was proposed that
the non-mitochondrial Oxa1 homologs may perform a
similar function as Oxa1, namely, in facilitating the insertion
and possible translocation of protein segments into and
across their respective membranes [22,26]. Recently, evi-
dence to confirm that the Oxa1/YidC/Alb3 proteins repre-
sent a conserved protein family mediating the insertion of
proteins into their respective membrane system was pre-
sented [62–64].
The chloroplast homolog of Oxa1, Alb3 was identified in
Arabidopsis a number of years ago [36]. Mutants failing to
synthesize Alb3 displayed an albino phenotype, thus indi-
cating this thylakoid membrane protein was required for
thylakoid membrane biogenesis. Earlier work from a num-
ber of research laboratories had indicated that at least three
distinct sorting pathways exist in chloroplasts to target
proteins to the thylakoid membrane [65]. Recently, Alb3
was demonstrated to play a crucial role in the insertion of at
least one membrane protein, the light harvesting chloro-
phyll-binding protein (LHCP) into the thylakoid membrane
of chloroplast [63]. These results implicate the role of Alb3
in at least one of the sorting pathways used by the thylakoid
membrane proteins and support the proposal that the non-
mitochondrial homologs of Oxa1 are involved in facilitating
protein translocation events [63].
In prokaryotes, the insertion into and translocation across
the periplasmic membrane of many proteins is mediated by
a general translocase, termed the SecYEG translocase (Sec-
dependent transport) [66–68]. The insertion of a number of
other membrane proteins, however, has been reported to
occur in a Sec-independent manner [24,25,68]. Although it
remained elusive for some time, the identity of this Sec-
independent translocase in E. coli, was recently shown to be
YidC, the Oxa1 homolog [62]. In addition to mediating Sec-
independent translocation, YidC was also shown to physi-
cally interact with and support the insertion of Sec-depend-
ent membrane proteins [62,69 – 72]. By physically
interacting with the SecYEG translocase, YidC has been
proposed to play a role in mediating the membrane insertion
of hydrophobic signal sequences or transmembrane domains
of protein which are undergoing translocation across the Sec
machinery [70–72]. Thus, YidC may serve to enhance the
lateral partitioning of membrane proteins into the periplas-
mic membrane.
The findings on the E. coli homolog of Oxa1, YidC, have
important implications for the mechanistic details of the
mode of the mitochondrial Oxa1 action. They also raise a
number of important questions. Firstly, the observations
imply that YidC may not operate alone as a translocase to
facilitate the membrane insertion of proteins, but rather it
can act in concert with the general protein translocation
machinery. Is this mode of action conserved for the mito-
chondrial homolog of YidC, Oxa1? As there is no mito-
chondrial Sec machinery (at least in yeast) [60], does this
mean that Oxa1 acts alone as a general protein translocase?
Further research, including the isolation and functional
reconstitution of Oxa1 complex, will be needed to answer
these questions.
Thus YidC in bacteria, Alb3 in chloroplasts, and Oxa1 in
mitochondria have similar functions; namely facilitating the
insertion of proteins into biological membranes. Taken
together, these findings demonstrate that the Sec-independ-
ent pathway of protein insertion into membranes has been
conserved throughout evolution. This observation is in
agreement with the endosymbiont hypothesis for the origin
of mitochondria and chloroplasts. In summary, the Oxa1/
YidC/Alb3 protein family represents a novel evolution-
arily conserved membrane protein insertion machinery
[29,62,64,73].
Note Added in Proof
Since the preparation of this manuscript two important
papers concerning Oxa1 and its role in the insertion mem-
brane proteins have been published. The first is from
Nargang and colleagues and deals with the characterization
of the Oxa1 complex from Neurospora crassa. The authors
report the purification of the Oxa1 complex and demonstrate
it to be a homo-oligomeric complex, possibly consisting of
four Oxa1 subunits [74]. Second, Fox and colleagues
recently presented genetic and biochemical evidence for
the involvement of three interacting membrane proteins,
Cox18, Pnt1 and Mss2, in the export of the specifically the
C-terminal region of Cox2 [75]. These findings suggest that
the N-terminal (Oxa1-dependent) and C-terminal regions of
Cox2, may be translocated across the inner membrane by
genetically distinct protein complexes.
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